Low Back Pain and Antibiotic Treatment

This study has been withdrawn prior to enrollment.
(Withdrawn: study halted prematurely, prior to enrollment of first participant)
Sponsor:
Collaborator:
Clalit Health Services
Information provided by:
Loewenstein Hospital
ClinicalTrials.gov Identifier:
NCT00285493
First received: February 1, 2006
Last updated: March 12, 2014
Last verified: June 2011
  Purpose

Clinical trial using antibiotic treatment, namely Rulid, after onset of low back pain.


Condition Intervention Phase
Low Back Pain
Drug: Antibiotics
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Phase 1 Study of Antibiotic Treatment for Low Back Pain

Resource links provided by NLM:


Further study details as provided by Loewenstein Hospital:

Primary Outcome Measures:
  • protocol designed to assess or examine persons or groups in a systematic way to identify specific markers for eligibility for further evaluation

Enrollment: 0
Study Start Date: January 2006
Study Completion Date: February 2006
Primary Completion Date: February 2006 (Final data collection date for primary outcome measure)
Detailed Description:

Clinical trial using antibiotic treatment, namely Rulid, after onset of low back pain.

  Eligibility

Ages Eligible for Study:   25 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

- Must be able to swallow tablets

Exclusion Criteria:

- Allergy to antibiotics

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00285493

Sponsors and Collaborators
Loewenstein Hospital
Clalit Health Services
Investigators
Study Director: Bambi Alyagon, MSc Loewenstein Hospital
Principal Investigator: Shoshana Weiler, MD Loewenstein Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00285493     History of Changes
Other Study ID Numbers: 230859
Study First Received: February 1, 2006
Last Updated: March 12, 2014
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Loewenstein Hospital:
low back pain

Additional relevant MeSH terms:
Back Pain
Low Back Pain
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Anti-Bacterial Agents
Antibiotics, Antitubercular
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions
Antitubercular Agents

ClinicalTrials.gov processed this record on October 19, 2014